PMS Statutory Instrument + MHRA Guidance released (Great Britain)
PMS Statutory Instrument + MHRA Guidance released (Great Britain)
Regulatory Affairs Medical Devices In Vitro Diagnostics PMS
Thursday, 06 February 2025
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On 16 December 2024, the Post-market Surveillance (PMS) Statutory Instrument, “The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024” which amends the UK Medical Device Regulations 2002 by adding Part 4A, was signed into law. These regulations will come into force following a 6-month transition period on 16 June 2025.
Play
PMS Statutory Instrument + MHRA Guidance released | Regulatory update
AI-generated audio
3:18
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist medical device manufacturers in preparing for the new PMS Statutory Instrument in Great Britain. These regulations apply to all medical devices, including in vitro diagnostic (IVD) devices and active implantable medical devices.
Manufacturers must implement and maintain a PMS system that is aligned with the risk classification and type of the medical device. This system should incorporate processes for collecting and analysing data, as well as ongoing monitoring of the device’s safety and performance after it has been marketed. The key elements of the PMS system include:
- PMS Plan: A required plan that outlines the systematic procedures for post-market surveillance activities.
- PMS Report (PMSR): Regular reports summarizing the findings from PMS data analysis for devices of lower risk categories.
- Periodic Safety Update Report (PSUR): For higher-risk devices, a PSUR must be submitted, offering a detailed assessment of the device’s benefit-risk balance.
The MHRA encourages manufacturers to review the guidance and take necessary steps to comply before the implementation date (16th June 2025). Industry feedback is welcomed through Trade Associations to refine the regulations where needed. These updates aim to improve patient safety and provide regulatory clarity for manufacturers operating in Great Britain.
The updated requirements and guidance do not apply to products placed on the Northern Ireland (NI) market as the EU IVD Regulation 2017/746 applies to products placed on the NI market, including PMS requirements.
These new regulations are part of wider regulatory reform as the UK government intends to introduce new regulations for medical devices that prioritise patient safety, give patients access to the medical devices they need and ensure the UK remains an attractive market for medical technology innovators. The reform will be implemented through secondary legislation. The first piece of legislation in this reform was the PMS Statutory Instrument. Further Statutory instruments will follow in 2025 and 2026 to introduce new pre-market requirements including international reliance, and further enhancements to the regulations.
What does it mean to you?
If you are placing medical devices, including in vitro diagnostic (IVD) devices and active implantable medical devices, on the Great Britain market, it is crucial to familiarize yourself with the new statutory instrument and understand its implications for your business. Begin implementing the requirements of this SI well ahead of its effective date, 16 June 2025, to ensure compliance.
Get in touch with our experts
Should you want to discuss this more in-depth with one of our consultants, please do not hesitate to contact us.
Discover more expert content
Previous
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
23 Jan 2024
Comprehensive Overview of Language Requirements under IVDR/MDR for Medical Device Manufacturers
EU Commission published MDR and IVDR language requirement tables for medical device manufacturers,...
Regulatory Affairs
9 Dec 2024
New MDCG Guidance document released on the implementation of the Master UDI-DI solution for contact lenses
On November 26th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance on the...
Regulatory Affairs
23 Feb 2024
EU Council Endorses Proposal to Amend IVDR and MDR Regulations
The Council of the European Union officially endorsed without any changes the proposal to amend...
Regulatory Affairs
30 Sep 2025
New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
23 Jan 2024
Comprehensive Overview of Language Requirements under IVDR/MDR for Medical Device Manufacturers
EU Commission published MDR and IVDR language requirement tables for medical device manufacturers,...
Regulatory Affairs
9 Dec 2024
New MDCG Guidance document released on the implementation of the Master UDI-DI solution for contact lenses
On November 26th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance on the...
Regulatory Affairs
23 Feb 2024
EU Council Endorses Proposal to Amend IVDR and MDR Regulations
The Council of the European Union officially endorsed without any changes the proposal to amend...
Regulatory Affairs
30 Sep 2025
New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
23 Jan 2024
Comprehensive Overview of Language Requirements under IVDR/MDR for Medical Device Manufacturers
EU Commission published MDR and IVDR language requirement tables for medical device manufacturers,...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe